Levbid Extended Release

Levbid®
(hyoscyamine sulfate, 0.375 mg) Extended-Release Tablets

DRUG DESCRIPTION

Levbid® (hysocyamine sulfate extended release tablets) extended-release tablets contain 0.375 mg of hyoscyamine sulfate in a formulation designed for oral b.i.d. dosage.

Hyoscyamine sulfate is one of the principal anticholinergic/antispasmodic components of belladonna alkaloids. The empirical formula is (C17H23NO3)2•H2SO4•2H2O and the molecular weight is 712.85. Chemically, it is benzeneacetic acid, a-(hydroxymethyl)-, 8-methyl-8-azabicyclo [3.2.1.] oct-3-yl ester, [3(S)-endo]-, sulfate (2:1), dihydrate with the following structure:

Levbid® (hyoscyamine sulfate) Structural Formula Illustration

Each Levbid® (hysocyamine sulfate extended release tablets) extended-release tablet also contains as inactive ingredients: calcium phosphate dibasic, ethylcellulose, lactose monohydrate, magnesium stearate, microcrystalline cellulose and stearic acid.

What are the possible side effects of hyoscyamine?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Stop using hyoscyamine and call your doctor at once if you have any of these serious side effects:

  • diarrhea;
  • confusion, hallucinations;
  • unusual thoughts or behavior;
  • fast, pounding, or uneven heart rate;
  • rash or flushing (warmth, redness, or tingly feeling); or
  • eye pain.

Less serious side effects may include:

  • dizziness, drowsiness, feeling...

Read All Potential Side Effects and See Pictures of Levbid Extended Release »

Last reviewed on RxList: 3/13/2009
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


GI Disorders

Get the latest treatment options.


NIH talks about Ebola on WebMD